Cytomegalovirus and atherosclerosis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 44, Issue 5-6, 1996, Pages 297-302

  Melnick, Joseph L ^a   Adam, Ervin ^a   DeBakey, Michael E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cytomegalovirus

Indexed keywords

CHOLESTEROL; VIRUS DNA; VIRUS PROTEIN;

ADOLESCENT; ADULT; ANIMAL; ARTERIOSCLEROSIS; BIOLOGICAL MODEL; CELL ADHESION; CELL CLONE; CELL CULTURE; CHICKEN; CHILD; COTURNIX; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; HERPES VIRUS INFECTION; HUMAN; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; LEUKOCYTE; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VIROLOGY; VIRUS CELL TRANSFORMATION;

ADOLESCENT; ADULT; ANIMALS; ARTERIOSCLEROSIS; CELL ADHESION; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CHICKENS; CHILD; CHOLESTEROL; CLONE CELLS; COTURNIX; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; ENDOTHELIUM, VASCULAR; HERPESVIRIDAE INFECTIONS; HUMANS; IN SITU HYBRIDIZATION; LEUKOCYTES; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; POLYMERASE CHAIN REACTION; RISK FACTORS; VIRAL PROTEINS;

EID: 0030341708     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. BEHBEHANI A. M., MELNICK J. L. and DEBAKEY M. E. (1965): Continous cell strains derived from human atheromatous lesions and their viral susceptibility. Proc. Soc. Exp. Biol. Med., 228, 759-763.
2. BENDITT E. P., BARRETT T. and MCDOUGALL J. K. (1983): Viruses in the etiology of atherosclerosis. Proc. Natl. Acad. Sci. USA, 80, 6386-6389.
3. BENDITT E. P. and BENDITT J. M. (1973): Evidence for monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA, 70, 1753-1756.
4. BRUGGEMAN C. A. and VAN DAM-MIERAS M. C. E. (1991): The possible role of cytomegalovirus in atherogenesis. Prog. Med. Virol., 38, 1-26.
5. DUMMER S., LEE A., BREINIG M. K., KORMOS R., HO M. and GRIFFITH B. (1994): Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J. Med. Virol., 44, 305-309.
6. ETINGIN O. R., SILVERSTEIN R. L. and HAJJAR D. P. (1991): Identification of a monocyte receptor on herpesvirs-infected endothelial cells. Proc. Natl. Acad. Sci. USA, 88, 7200-7203.
7. FABRICANT C. G., FABRICANT J., LITRENTA M. M. and MINICK C. R. (1978): Virus-induced atherosclerosis. J. Exp. Med., 148, 335-340.
8. FABRICANT C. G., FABRICANT J., MINICK C. R. and LITRENTA M. M. (1983): Herpesvirus-induced atherosclerosis in chickens. Fed. Proc., 42, 2476-2479.
9. GRATTAN M. T., MORENAO-CABRAL C. E., STARNES V. A., OYER P., STINSON E. B. and SHUMWAY N. E. (1989): Cytomegalovirus infection is associated with cardiac alograft rejection and atherosclerosis. J. Am. Med. Assn., 261, 3561-3566.
10. HAJJAR D. P., FABRICANT C. G., MINICK C. R. and FABRICANT J. (1986): Virus-induced atherosclerosis: herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am. J. Pathol., 122, 62-70.
11. HENDRIX M. G. R., DORMANS P. H. J., KITSLAAR P., BOSMAN F. and BRUGGEMAN C. A. (1989): The presence of cytomegalovirus necleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am. J. Pathol., 134, 23-28.
12. KEY S., VARCELLOTTI G. M., WINKELMANN J. D., MOLDON C. V., GOODMAN J. L., ESMON N. L., ESMON C. T. and JACOB H. S. (1990): Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc. Natl. Acad. Sci., 87, 7095-7099.
13. MELNICK J. L., ADAM E. and DEBAKEY M. E. (1993): Cytomegalovirus and atherosclerosis. Eur. Heart J., 14 (suppl. K), 30-38.
14. MELNICK J. L., ADAM E. and DEBAKEY M. E. (1995): Cytomegalovirus and atherosclerosis. Bioessays, 17, 899-903.
15. MELNICK J. L., HU C., BUREK J., ADAM E. and DEBAKEY M. E. (1994): Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol., 42, 170-174.
16. MELNICK J. L., PETRIE B. L., DREESMAN G. R., BUREK J., MCCOLLUM C. H. and DEBAKEY M. E. (1983): Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet, 2, 644-647.
17. NEITO F. J., ADAM E., SORLIE P., FARZADEGAN H., MALNICK J. L., COMSTOCK G. W. and SZKLO M. (1995): JAMA (in press).
18. PATERSON J. and COTTRAL G. E. (1950): Experimental coronary sclerosis. III. Lymphomatosis as a cause of coronary sclerosis in chickens. Arch. Pathol., 49, 699.
19. PENN A., GARTE S. J., WARREN L., NESTA D. and MINICK B. (1986): Transforming gene in atherosclerotic plaque DNA. Proc. Natl. Acad. Sci. USA, 83, 7951-7955.
20. PETRIE B. L., ADAM E. and MELNICK J. L. (1988): Association of herpesvirus/cytomegalovirus infections with human atherosclerosis. Prog. Med. Virol., 35, 21-38.
21. PETRIE B. L., MELNICK J. L., ADAM E., BUREK J., MCCOLLUM C. H. and DEBACKEY M. E. (1987): Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue. J. Infect. Dis., 55, 158-159.
22. ROSS R. (1986): The pathogenesis of atherosclerosis. An update. N. Engl. J. Med., 314, 488-500.
23. SHIH J. C. H., PULLMAN R. P. and JAO K. J. (1983): Genetic selection, general characterization, and history of atherosclerosis-susceptible and -resistant Japanese quail. Ateriosclerosis, 49, 41-53.
24. SMILEY M. L., MAR E.-C. and HUANG E.-S. (1988): Cytomegalovirus infection and viral-induced transformation of human epithelial cells. J. Med. Virol., 25, 213-226.
25. SORLIE P. D., ADAM E., MELNICK S. L., FOLSOM A., SKELTON T., CHAMBLESS L. E., BARNOES R. and MELNICK J. L. (1994): Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J. Med. Virol., 42, 33-37.
26. SPAN A. J. M., VAN BOVEN C. P. A. and BRUGGEMAN C. A. (1989): The effect of cytomegalovirus infection on the adherence of polymorphonuclear leukocytes to endothelial cells. Eur. J. Clin. Invest., 19, 542-548.
27. SPEIR E., MODALI R., HUANG E.-S., LEON M. B., SHAWL F., FINKEL T. and EPSTEIN S. E. (1994): Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Sciences, 165, 391-394.
28. TANAKA S., TOH Y., MORI R., KOMORI K., OKADOME K. and SUGIMACHI K. (1992): Possible role of cytomegalovirus in the pathogenesis of inflammatory aortic disease. J. Vasc. Surg., 16, 274.
29. VISSER M. R., JACOB H. S., GOODMAN J. L., MCCARTHY J. B., FURCHT L. T. and VERCELLOTTI G. M. (1989): Granulocyte-mediated injury to herpes simplex virus-infected human endothelium. Lab. Invest., 60, 296-304.
30. YAMASHIROYA H. M., GHOCH L., YANG R. and ROBERTSON A. L. JR. (1988): Herpesviridae in the coronary arteries and aorta of young trauma victims. Am. J. Pathol., 130, 71-79.